Loading...
Exact Sciences Corporation
EXAS•NASDAQ
Healthcare
Medical - Diagnostics & Research
$48.49
$-0.28(-0.57%)
Exact Sciences Corporation (EXAS) Financial Performance & Income Statement Overview
Review Exact Sciences Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.37%
↑ 10.37%
Operating Income Growth
-387.74%
↓ 387.74%
Net Income Growth
-403.97%
↓ 403.97%
Operating Cash Flow Growth
34.86%
↑ 34.86%
Operating Margin
-36.55%
↓ 36.55%
Gross Margin
68.19%
↑ 68.19%
Net Profit Margin
-36.06%
↓ 36.06%
ROE
-36.42%
↓ 36.42%
ROIC
-19.85%
↓ 19.85%
Exact Sciences Corporation (EXAS) Income Statement & Financial Overview
Review Exact Sciences Corporation's (EXAS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $713.42M | $708.65M | $699.26M | $637.52M |
| Cost of Revenue | $284.20M | $196.10M | $213.16M | $170.10M |
| Gross Profit | $429.22M | $512.55M | $486.11M | $467.42M |
| Gross Profit Ratio | $0.60 | $0.72 | $0.70 | $0.73 |
| R&D Expenses | $99.62M | $100.10M | $120.88M | $110.61M |
| SG&A Expenses | $435.64M | $411.90M | $387.13M | $435.50M |
| Operating Expenses | $1.31B | $551.96M | $508.01M | $569.69M |
| Total Costs & Expenses | $1.59B | $748.06M | $721.17M | $739.79M |
| Interest Income | -$639000.00 | $11.58M | $0.00 | $0.00 |
| Interest Expense | $8.94M | $8.94M | $111000.00 | $7.94M |
| Depreciation & Amortization | $53.15M | $54.77M | $53.00M | $53.94M |
| EBITDA | -$813.88M | $26.28M | $34.87M | -$46.54M |
| EBITDA Ratio | -$1.14 | $0.04 | $0.05 | -$0.07 |
| Operating Income | -$876.35M | -$39.40M | -$21.91M | -$106.69M |
| Operating Income Ratio | -$1.23 | -$0.06 | -$0.03 | -$0.17 |
| Other Income/Expenses (Net) | $23.15M | $1.98M | $11.91M | -$1.73M |
| Income Before Tax | -$853.20M | -$37.43M | -$14.35M | -$108.42M |
| Income Before Tax Ratio | -$1.20 | -$0.05 | -$0.02 | -$0.17 |
| Income Tax Expense | -$11.38M | $808000.00 | $1.46M | $1.81M |
| Net Income | -$864.59M | -$38.24M | -$15.81M | -$110.23M |
| Net Income Ratio | -$1.21 | -$0.05 | -$0.02 | -$0.17 |
| EPS | -$4.67 | -$0.21 | -$0.09 | -$0.60 |
| Diluted EPS | -$4.67 | -$0.21 | -$0.09 | -$0.60 |
| Weighted Avg Shares Outstanding | $185.31M | $184.79M | $184.31M | $182.35M |
| Weighted Avg Shares Outstanding (Diluted) | $185.31M | $184.79M | $184.31M | $182.35M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan